Subjects will be screened within 28 days. Each treatment session will consist of 2 PSG nights, study drug administration and noise model is conducted on second night.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Enrollment
52
GSK Investigational Site
Guildford, Surrey, United Kingdom
Total Sleep Time measured overnight across four treatment sessions (4 weeks)
Time frame: 4 weeks
The effects on daytime cognitive function following dosing across four treatment sessions (4 weeks)
Time frame: 4 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.